BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24061511)

  • 1. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.
    Moon KA; Guallar E; Umans JG; Devereux RB; Best LG; Francesconi KA; Goessler W; Pollak J; Silbergeld EK; Howard BV; Navas-Acien A
    Ann Intern Med; 2013 Nov; 159(10):649-59. PubMed ID: 24061511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.
    Zheng LY; Umans JG; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Bandeen-Roche K; Guallar E; Howard BV; Weaver VM; Navas-Acien A
    Epidemiology; 2015 Jul; 26(4):601-12. PubMed ID: 25929811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.
    Kaufman JA; Mattison C; Fretts AM; Umans JG; Cole SA; Voruganti VS; Goessler W; Best LG; Zhang Y; Tellez-Plaza M; Navas-Acien A; Gribble MO
    Environ Res; 2021 Apr; 195():110864. PubMed ID: 33581093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.
    Newman JD; Navas-Acien A; Kuo CC; Guallar E; Howard BV; Fabsitz RR; Devereux RB; Umans JG; Francesconi KA; Goessler W; Best LT; Tellez-Plaza M
    Am J Epidemiol; 2016 Dec; 184(11):806-817. PubMed ID: 27810857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadmium exposure and incident cardiovascular disease.
    Tellez-Plaza M; Guallar E; Howard BV; Umans JG; Francesconi KA; Goessler W; Silbergeld EK; Devereux RB; Navas-Acien A
    Epidemiology; 2013 May; 24(3):421-9. PubMed ID: 23514838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Does exposure to low or moderate levels of arsenic increase the risk for cardiovascular disease?
    Ann Intern Med; 2013 Nov; 159(10):I-20. PubMed ID: 24400335
    [No Abstract]   [Full Text] [Related]  

  • 7. Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study.
    Kuo CC; Howard BV; Umans JG; Gribble MO; Best LG; Francesconi KA; Goessler W; Lee E; Guallar E; Navas-Acien A
    Diabetes Care; 2015 Apr; 38(4):620-7. PubMed ID: 25583752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians.
    Kim NH; Mason CC; Nelson RG; Afton SE; Essader AS; Medlin JE; Levine KE; Hoppin JA; Lin C; Knowler WC; Sandler DP
    Am J Epidemiol; 2013 May; 177(9):962-9. PubMed ID: 23504692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study.
    García-Esquinas E; Pollán M; Umans JG; Francesconi KA; Goessler W; Guallar E; Howard B; Farley J; Best LG; Navas-Acien A
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1944-53. PubMed ID: 23800676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.
    Navas-Acien A; Umans JG; Howard BV; Goessler W; Francesconi KA; Crainiceanu CM; Silbergeld EK; Guallar E
    Environ Health Perspect; 2009 Sep; 117(9):1428-33. PubMed ID: 19750109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic and cardiovascular disease: new evidence from the United States.
    Chen Y; Karagas MR
    Ann Intern Med; 2013 Nov; 159(10):713-4. PubMed ID: 24061555
    [No Abstract]   [Full Text] [Related]  

  • 12. Cadmium exposure and incident peripheral arterial disease.
    Tellez-Plaza M; Guallar E; Fabsitz RR; Howard BV; Umans JG; Francesconi KA; Goessler W; Devereux RB; Navas-Acien A
    Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):626-33. PubMed ID: 24255048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Low-Moderate Arsenic Exposure and Arsenic Metabolism with Incident Diabetes and Insulin Resistance in the Strong Heart Family Study.
    Grau-Perez M; Kuo CC; Gribble MO; Balakrishnan P; Jones Spratlen M; Vaidya D; Francesconi KA; Goessler W; Guallar E; Silbergeld EK; Umans JG; Best LG; Lee ET; Howard BV; Cole SA; Navas-Acien A
    Environ Health Perspect; 2017 Dec; 125(12):127004. PubMed ID: 29373862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Exposure From Drinking Water and the Incidence of CKD in Low to Moderate Exposed Areas of Taiwan: A 14-Year Prospective Study.
    Hsu LI; Hsieh FI; Wang YH; Lai TS; Wu MM; Chen CJ; Chiou HY; Hsu KH
    Am J Kidney Dis; 2017 Dec; 70(6):787-797. PubMed ID: 28844585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine arsenic and prevalent albuminuria: evidence from a population-based study.
    Zheng LY; Umans JG; Tellez-Plaza M; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Guallar E; Howard BV; Weaver VM; Navas-Acien A
    Am J Kidney Dis; 2013 Mar; 61(3):385-94. PubMed ID: 23142528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.
    Gribble MO; Crainiceanu CM; Howard BV; Umans JG; Francesconi KA; Goessler W; Zhang Y; Silbergeld EK; Guallar E; Navas-Acien A
    Environ Health; 2013 Dec; 12():107. PubMed ID: 24321145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study.
    Kuo CC; Balakrishnan P; Gribble MO; Best LG; Goessler W; Umans JG; Navas-Acien A
    Environ Int; 2022 Jan; 159():107029. PubMed ID: 34890900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study.
    Mateen FJ; Grau-Perez M; Pollak JS; Moon KA; Howard BV; Umans JG; Best LG; Francesconi KA; Goessler W; Crainiceanu C; Guallar E; Devereux RB; Roman MJ; Navas-Acien A
    Environ Res; 2017 Aug; 157():127-134. PubMed ID: 28554006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study.
    Chen Y; Graziano JH; Parvez F; Liu M; Slavkovich V; Kalra T; Argos M; Islam T; Ahmed A; Rakibuz-Zaman M; Hasan R; Sarwar G; Levy D; van Geen A; Ahsan H
    BMJ; 2011 May; 342():d2431. PubMed ID: 21546419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-moderate arsenic exposure and respiratory in American Indian communities in the Strong Heart Study.
    Powers M; Sanchez TR; Grau-Perez M; Yeh F; Francesconi KA; Goessler W; George CM; Heaney C; Best LG; Umans JG; Brown RH; Navas-Acien A
    Environ Health; 2019 Nov; 18(1):104. PubMed ID: 31779614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.